Compare Eupraxia Pharmaceuticals (EPRX) vs. Competitors
47 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| EPRXEupraxia Pharmaceuticals | $6.76 | $468.92M | -6.66 | 24.04% | Strong Buy | Unlock the EPRX analyst price target with TipRanks Premium | EPRX | Unlock the EPRX top-analyst price target with TipRanks Premium | ||
| TSE:DRUGBright Minds Biosciences | CAD 26.11 | CAD 296.61M | -9.00 | -64.14% | Strong Buy | Unlock the TSE:DRUG analyst price target with TipRanks Premium | EPRX vs TSE:DRUG | Unlock the TSE:DRUG top-analyst price target with TipRanks Premium | ||
| TSE:MYNDMYND Life Sciences | CAD 0.07 | CAD 3.35M | -2.18 | 0.00% | ― | Unlock the TSE:MYND analyst price target with TipRanks Premium | EPRX vs TSE:MYND | Unlock the TSE:MYND top-analyst price target with TipRanks Premium | ||
| TSE:MBIOMindbio Therapeutics Corp. | CAD 0.09 | CAD 655.48K | -0.02 | -97.75% | ― | Unlock the TSE:MBIO analyst price target with TipRanks Premium | EPRX vs TSE:MBIO | Unlock the TSE:MBIO top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| EPRX | Eupraxia Pharmaceuticals | 6.76 | 1.09 | 19.22% | |
| TSE:DRUG | Bright Minds Biosciences | 26.11 | -46.70 | -64.14% | |
| TSE:MYND | MYND Life Sciences | 0.07 | 0.00 | 0.00% | |
| TSE:MBIO | Mindbio Therapeutics Corp. | 0.09 | -1.91 | -95.50% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
